New Frontier Health Corporation

(NASDAQ:NFC)

Latest On New Frontier Health Corporation (NFC):

Date/Time Type Description Signal Details
2020-11-26 20:57 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 00:19 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:36 ESTFinancialsCompany financials have been released.Neutral
2020-11-03 12:21 ESTFinancialsCompany financials have been released.Neutral
2020-10-22 05:09 ESTAnalyst RatingThe Analyst Target Price has increased from $12.48 to $12.49.Buy
2020-10-21 09:08 ESTAnalyst RatingThe Analyst Target Price has increased from $12.47 to $12.48.Buy
2020-10-20 17:35 ESTAnalyst RatingThe Analyst Target Price has increased from $12.4 to $12.47.Buy
2020-10-17 05:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.42 to $12.4.Neutral
2020-10-16 05:11 ESTAnalyst RatingThe Analyst Target Price has increased from $12.38 to $12.42.Buy
2020-10-15 05:13 ESTAnalyst RatingThe Analyst Target Price has increased from $12.36 to $12.38.Buy
2020-10-14 09:12 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.47 to $12.36.Neutral
2020-10-13 05:21 ESTAnalyst RatingThe Analyst Target Price has increased from $12.3 to $12.47.Buy
2020-10-08 09:43 ESTAnalyst RatingThe Analyst Target Price has increased from $12.28 to $12.3.Buy
2020-10-07 09:29 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.3 to $12.28.Neutral
2020-10-04 05:27 ESTAnalyst RatingThe Analyst Target Price has increased from $12.28 to $12.3.Buy
2020-10-03 09:32 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.31 to $12.28.Neutral
2020-10-01 21:25 ESTAnalyst RatingThe Analyst Target Price has increased from $12.27 to $12.31.Buy
2020-10-01 09:31 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.28 to $12.27.Neutral
2020-09-30 17:46 ESTAnalyst RatingThe Analyst Target Price has increased from $12.27 to $12.28.Buy
2020-09-29 05:14 ESTAnalyst RatingThe Analyst Target Price has increased from $12.26 to $12.27.Buy
2020-09-26 13:31 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 05:22 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.28 to $12.26.Neutral
2020-09-25 17:16 ESTAnalyst RatingThe Analyst Target Price has increased from $12.18 to $12.28.Buy
2020-09-25 05:25 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.23 to $12.18.Neutral
2020-09-24 05:16 ESTAnalyst RatingThe Analyst Target Price has increased from $12.19 to $12.23.Buy
2020-09-23 09:35 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.27 to $12.19.Neutral
2020-09-22 17:31 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.28 to $12.27.Neutral
2020-09-22 09:39 ESTAnalyst RatingThe Analyst Target Price has decreased from $16.78 to $12.28.Neutral
2020-09-21 09:42 ESTAnalyst RatingThe Analyst Target Price has increased from $12.28 to $16.78.Buy
2020-09-18 17:45 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.42 to $12.28.Neutral
2020-09-18 05:43 ESTAnalyst RatingThe Analyst Target Price has increased from $12.37 to $12.42.Buy
2020-09-17 05:37 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:37 ESTAnalyst RatingThe Analyst Target Price has increased from $12.32 to $12.37.Buy
2020-09-16 05:11 ESTAnalyst RatingThe Analyst Target Price has increased from $12.29 to $12.32.Buy
2020-09-12 05:10 ESTAnalyst RatingThe Analyst Target Price has increased from $12.28 to $12.29.Buy
2020-09-11 17:22 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.29 to $12.28.Neutral
2020-09-11 05:10 ESTAnalyst RatingThe Analyst Target Price has increased from $12.28 to $12.29.Buy
2020-09-10 05:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.31 to $12.28.Neutral
2020-09-09 05:54 ESTAnalyst RatingThe Analyst Target Price has increased from $12.29 to $12.31.Buy
2020-09-08 01:16 ESTAnalyst RatingThe Analyst Target Price has increased from $12.28 to $12.29.Buy
2020-09-05 05:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.31 to $12.28.Neutral
2020-09-04 21:17 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.4 to $12.31.Neutral
2020-09-03 05:33 ESTAnalyst RatingThe Analyst Target Price has increased from $12.36 to $12.4.Buy
2020-09-02 05:11 ESTAnalyst RatingThe Analyst Target Price has increased from $12.33 to $12.36.Buy
2020-09-01 05:11 ESTAnalyst RatingThe Analyst Target Price has increased from $12.29 to $12.33.Buy
2020-08-31 13:07 ESTFinancialsCompany financials have been released.Neutral
2020-08-29 05:07 ESTAnalyst RatingThe Analyst Target Price has increased from $12.28 to $12.29.Buy
2020-08-28 17:11 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.34 to $12.28.Neutral
2020-08-28 05:08 ESTAnalyst RatingThe Analyst Target Price has increased from $12.31 to $12.34.Buy
2020-08-27 05:11 ESTAnalyst RatingThe Analyst Target Price has increased from $12.3 to $12.31.Buy

About New Frontier Health Corporation (NFC):

New Frontier Health Corporation provides healthcare services. It operates a network of hospital inpatient departments and integrated outpatient clinics, including satellite feeder clinics. The company's facilities include 24/7 emergency rooms, intensive care units, neonatal intensive care units, operating rooms, clinical laboratories, radiology, and blood banking services. It operates five hospitals and eight clinics in northern China; two hospitals and four clinics in eastern China; and two hospitals and two clinics in southern China. The company is based in Beijing, China.

NFC Quotes by TradingView

See Advanced Chart

General

  • Name New Frontier Health Corporation
  • Symbol NFC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorFinancial
  • IndustryClosed-End Fund - Debt
  • Last Split Factor1:2
  • Last Split Date2004-02-12
  • Fiscal Year EndDecember
  • IPO Date2018-07-27
  • Web URLhttp://www.nfh.com.cn
View More

Valuation

  • Forward PE 188.68
  • Price/Sales (Trailing 12 Mt.) 3.27
  • Price/Book (Most Recent Quarter) 0.88
  • Enterprise Value Revenue 0.68
  • Enterprise Value EBITDA 5.88
View More

Financials

  • Most Recent Quarter 2020-06-30
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 409.08 million
  • Analyst Target Price $12.49
  • Book Value Per Share $0.12
View More

Share Statistics

  • Shares Outstanding 28.75 million
  • Shares Float 61.89 million
  • % Held by Insiders 917%
  • % Held by Institutions 40.41%
View More

Technicals

  • Beta 0.12
  • 52 Week High $9.85
  • 52 Week Low $7.3
  • 50 Day Moving Average 8.16
  • 200 Day Moving Average 8.2
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
View More

New Frontier Health Corporation (NFC) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

New Frontier Health Corporation (NFC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

New Frontier Health Corporation (NFC) Chart:

New Frontier Health Corporation (NFC) News:

Below you will find a list of latest news for New Frontier Health Corporation (NFC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

New Frontier Health Corporation (NFC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

New Frontier Health Corporation (NFC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-27424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1737422/000110465920066088/0001104659-20-066088-index.htm
2018-05-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1737422/000000000018016127/0000000000-18-016127-index.htm
2018-06-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1737422/000000000018018862/0000000000-18-018862-index.htm
2018-06-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1737422/000000000018019185/0000000000-18-019185-index.htm
2019-10-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1737422/000000000019014348/0000000000-19-014348-index.htm
2019-11-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1737422/000000000019015314/0000000000-19-015314-index.htm
2019-11-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1737422/000000000019015677/0000000000-19-015677-index.htm
2019-11-25UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1737422/000000000019015836/0000000000-19-015836-index.htm
2020-01-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1737422/000000000020000737/0000000000-20-000737-index.htm
2018-06-27CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1737422/000087666118000746/0000876661-18-000746-index.htm
2019-12-1925-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1737422/000087666119001287/0000876661-19-001287-index.htm
2020-01-02SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1737422/000090445420000002/0000904454-20-000002-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1737422/000108514619000786/0001085146-19-000786-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1737422/000108514620000634/0001085146-20-000634-index.htm
2019-10-25PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1737422/000110465919056358/0001104659-19-056358-index.htm
2019-10-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1737422/000110465919056518/0001104659-19-056518-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000110465919056539/0001104659-19-056539-index.htm
2019-10-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1737422/000110465919056541/0001104659-19-056541-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000110465919060511/0001104659-19-060511-index.htm
2019-11-06DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1737422/000110465919060514/0001104659-19-060514-index.htm
2019-11-12PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1737422/000110465919062664/0001104659-19-062664-index.htm
2019-11-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1737422/000110465919062758/0001104659-19-062758-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737422/000110465919064082/0001104659-19-064082-index.htm
2019-11-22PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1737422/000110465919066661/0001104659-19-066661-index.htm
2019-11-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1737422/000110465919066702/0001104659-19-066702-index.htm
2019-11-29DEFM14ADefinitive proxy statement relating to merger or acquisitionhttps://www.sec.gov/Archives/edgar/data/1737422/000110465919068418/0001104659-19-068418-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000110465919068950/0001104659-19-068950-index.htm
2019-12-02DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1737422/000110465919068953/0001104659-19-068953-index.htm
2019-12-06DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1737422/000110465919070365/0001104659-19-070365-index.htm
2019-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000110465919070367/0001104659-19-070367-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000110465919072108/0001104659-19-072108-index.htm
2019-12-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1737422/000110465919074961/0001104659-19-074961-index.htm
2019-12-208-A12B/ARegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1737422/000110465919074972/0001104659-19-074972-index.htm
2019-12-2620FR12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1737422/000110465919076170/0001104659-19-076170-index.htm
2019-12-26F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1737422/000110465919076214/0001104659-19-076214-index.htm
2019-12-30SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1737422/000110465919076768/0001104659-19-076768-index.htm
2019-12-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1737422/000110465919076842/0001104659-19-076842-index.htm
2020-01-24F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1737422/000110465920006766/0001104659-20-006766-index.htm
2020-01-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1737422/000110465920007504/0001104659-20-007504-index.htm
2020-02-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1737422/000110465920022803/0001104659-20-022803-index.htm
2020-03-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1737422/000110465920038546/0001104659-20-038546-index.htm
2020-03-3120-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737422/000110465920041224/0001104659-20-041224-index.htm
2020-03-31POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1737422/000110465920041227/0001104659-20-041227-index.htm
2020-05-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1737422/000110465920066087/0001104659-20-066087-index.htm
2020-05-27424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1737422/000110465920066088/0001104659-20-066088-index.htm
2020-08-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1737422/000110465920089371/0001104659-20-089371-index.htm
2020-08-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1737422/000110465920096132/0001104659-20-096132-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1737422/000110465920099146/0001104659-20-099146-index.htm
2020-08-27424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1737422/000110465920099302/0001104659-20-099302-index.htm
2018-04-27DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1737422/000114420418023248/0001144204-18-023248-index.htm
2018-06-04S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1737422/000114420418032700/0001144204-18-032700-index.htm
2018-06-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1737422/000114420418032703/0001144204-18-032703-index.htm
2018-06-14S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1737422/000114420418034124/0001144204-18-034124-index.htm
2018-06-20S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1737422/000114420418034913/0001144204-18-034913-index.htm
2018-06-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1737422/000114420418034914/0001144204-18-034914-index.htm
2018-06-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1737422/000114420418035263/0001144204-18-035263-index.htm
2018-06-22S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1737422/000114420418035266/0001144204-18-035266-index.htm
2018-06-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1737422/000114420418035639/0001144204-18-035639-index.htm
2018-06-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1737422/000114420418035640/0001144204-18-035640-index.htm
2018-06-268-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1737422/000114420418035814/0001144204-18-035814-index.htm
2018-06-27S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1737422/000114420418036167/0001144204-18-036167-index.htm
2018-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420418036183/0001144204-18-036183-index.htm
2018-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420418036186/0001144204-18-036186-index.htm
2018-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420418036187/0001144204-18-036187-index.htm
2018-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420418036188/0001144204-18-036188-index.htm
2018-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420418036189/0001144204-18-036189-index.htm
2018-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420418036190/0001144204-18-036190-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420418036495/0001144204-18-036495-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420418036497/0001144204-18-036497-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420418036499/0001144204-18-036499-index.htm
2018-06-29424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1737422/000114420418036661/0001144204-18-036661-index.htm
2018-06-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420418036689/0001144204-18-036689-index.htm
2018-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000114420418037276/0001144204-18-037276-index.htm
2018-07-09SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1737422/000114420418037700/0001144204-18-037700-index.htm
2018-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000114420418037886/0001144204-18-037886-index.htm
2018-07-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000114420418039601/0001144204-18-039601-index.htm
2018-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737422/000114420418043821/0001144204-18-043821-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737422/000114420418059278/0001144204-18-059278-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1737422/000114420419017454/0001144204-19-017454-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420419017550/0001144204-19-017550-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737422/000114420419017551/0001144204-19-017551-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737422/000114420419026403/0001144204-19-026403-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000114420419036554/0001144204-19-036554-index.htm
2019-07-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1737422/000114420419036562/0001144204-19-036562-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000114420419036565/0001144204-19-036565-index.htm
2019-07-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1737422/000114420419036566/0001144204-19-036566-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000114420419037123/0001144204-19-037123-index.htm
2019-08-01DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1737422/000114420419037125/0001144204-19-037125-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737422/000114420419039894/0001144204-19-039894-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737422/000114420419043890/0001144204-19-043890-index.htm
2019-09-09DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1737422/000114420419043892/0001144204-19-043892-index.htm
2019-09-11PREM14APreliminary proxy statements relating to merger or acquisitionhttps://www.sec.gov/Archives/edgar/data/1737422/000114420419044280/0001144204-19-044280-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1737422/000142284820000035/0001422848-20-000035-index.htm
2018-06-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1737422/999999999518001645/9999999995-18-001645-index.htm
2020-01-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1737422/999999999520000178/9999999995-20-000178-index.htm
2020-04-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1737422/999999999520000707/9999999995-20-000707-index.htm